Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In episode 17 of this series, Arthur Kim, MD, provides a brief update on the latest COVID-19 treatment options and guidelines. After the update, Dr. Kim answers questions submitted by healthcare professionals on various aspects of COVID-19.
Arthur Kim, MD
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Clinical Care Options’ (CCO) commentary from Dr. Sharon Lewin on new data on monoclonal antibodies for COVID-19 prevention and treatment
Clinical Care Options’ (CCO) commentary from Dr. Gregory Olson and colleagues on COVID-19 vaccination in immunocompromised patients
Clinical Care Options’ (CCO) expert commentary from Dr. Renslow Sherer and colleagues on the risk of severe COVID-19 in patients with HIV and/or other forms of immunocompromise
Clinical Care Options’ (CCO) commentary from a person with HIV on what it was like living through the COVID-19 pandemic as a long-term HIV survivor